Conversion of adult endothelium to immunocompetent haematopoietic stem cells

Raphael Lis, Charles C. Karrasch, Michael G. Poulos, Balvir Kunar, David Redmond, Jose G.Barcia Duran, Chaitanya R. Badwe, William Schachterle, Michael Ginsberg, Jenny Xiang, Arash Rafii Tabrizi, Koji Shido, Zev Rosenwaks, Olivier Elemento, Nancy A. Speck, Jason M. Butler, Joseph M. Scandura, Shahin Rafii

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Developmental pathways that orchestrate the fleeting transition of endothelial cells into haematopoietic stem cells remain undefined. Here we demonstrate a tractable approach for fully reprogramming adult mouse endothelial cells to haematopoietic stem cells (rEC-HSCs) through transient expression of the transcription-factor-encoding genes Fosb, Gfi1, Runx1, and Spi1 (collectively denoted hereafter as FGRS) and vascular-niche-derived angiocrine factors. The induction phase (days 0-8) of conversion is initiated by expression of FGRS in mature endothelial cells, which results in endogenous Runx1 expression. During the specification phase (days 8-20), RUNX1 + FGRS-transduced endothelial cells commit to a haematopoietic fate, yielding rEC-HSCs that no longer require FGRS expression. The vascular niche drives a robust self-renewal and expansion phase of rEC-HSCs (days 20-28). rEC-HSCs have a transcriptome and long-term self-renewal capacity similar to those of adult haematopoietic stem cells, and can be used for clonal engraftment and serial primary and secondary multi-lineage reconstitution, including antigen-dependent adaptive immune function. Inhibition of TGFβ and CXCR7 or activation of BMP and CXCR4 signalling enhanced generation of rEC-HSCs. Pluripotency-independent conversion of endothelial cells into autologous authentic engraftable haematopoietic stem cells could aid treatment of haematological disorders.

Original languageEnglish
Pages (from-to)439-445
Number of pages7
JournalNature
Volume545
Issue number7655
DOIs
Publication statusPublished - 25 May 2017

Fingerprint

Hematopoietic Stem Cells
Endothelium
Endothelial Cells
Blood Vessels
Adult Stem Cells
Transcriptome
Transcription Factors
Antigens

ASJC Scopus subject areas

  • General

Cite this

Lis, R., Karrasch, C. C., Poulos, M. G., Kunar, B., Redmond, D., Duran, J. G. B., ... Rafii, S. (2017). Conversion of adult endothelium to immunocompetent haematopoietic stem cells. Nature, 545(7655), 439-445. https://doi.org/10.1038/nature22326

Conversion of adult endothelium to immunocompetent haematopoietic stem cells. / Lis, Raphael; Karrasch, Charles C.; Poulos, Michael G.; Kunar, Balvir; Redmond, David; Duran, Jose G.Barcia; Badwe, Chaitanya R.; Schachterle, William; Ginsberg, Michael; Xiang, Jenny; Tabrizi, Arash Rafii; Shido, Koji; Rosenwaks, Zev; Elemento, Olivier; Speck, Nancy A.; Butler, Jason M.; Scandura, Joseph M.; Rafii, Shahin.

In: Nature, Vol. 545, No. 7655, 25.05.2017, p. 439-445.

Research output: Contribution to journalArticle

Lis, R, Karrasch, CC, Poulos, MG, Kunar, B, Redmond, D, Duran, JGB, Badwe, CR, Schachterle, W, Ginsberg, M, Xiang, J, Tabrizi, AR, Shido, K, Rosenwaks, Z, Elemento, O, Speck, NA, Butler, JM, Scandura, JM & Rafii, S 2017, 'Conversion of adult endothelium to immunocompetent haematopoietic stem cells', Nature, vol. 545, no. 7655, pp. 439-445. https://doi.org/10.1038/nature22326
Lis R, Karrasch CC, Poulos MG, Kunar B, Redmond D, Duran JGB et al. Conversion of adult endothelium to immunocompetent haematopoietic stem cells. Nature. 2017 May 25;545(7655):439-445. https://doi.org/10.1038/nature22326
Lis, Raphael ; Karrasch, Charles C. ; Poulos, Michael G. ; Kunar, Balvir ; Redmond, David ; Duran, Jose G.Barcia ; Badwe, Chaitanya R. ; Schachterle, William ; Ginsberg, Michael ; Xiang, Jenny ; Tabrizi, Arash Rafii ; Shido, Koji ; Rosenwaks, Zev ; Elemento, Olivier ; Speck, Nancy A. ; Butler, Jason M. ; Scandura, Joseph M. ; Rafii, Shahin. / Conversion of adult endothelium to immunocompetent haematopoietic stem cells. In: Nature. 2017 ; Vol. 545, No. 7655. pp. 439-445.
@article{ec984b451114413cb775116a377b032b,
title = "Conversion of adult endothelium to immunocompetent haematopoietic stem cells",
abstract = "Developmental pathways that orchestrate the fleeting transition of endothelial cells into haematopoietic stem cells remain undefined. Here we demonstrate a tractable approach for fully reprogramming adult mouse endothelial cells to haematopoietic stem cells (rEC-HSCs) through transient expression of the transcription-factor-encoding genes Fosb, Gfi1, Runx1, and Spi1 (collectively denoted hereafter as FGRS) and vascular-niche-derived angiocrine factors. The induction phase (days 0-8) of conversion is initiated by expression of FGRS in mature endothelial cells, which results in endogenous Runx1 expression. During the specification phase (days 8-20), RUNX1 + FGRS-transduced endothelial cells commit to a haematopoietic fate, yielding rEC-HSCs that no longer require FGRS expression. The vascular niche drives a robust self-renewal and expansion phase of rEC-HSCs (days 20-28). rEC-HSCs have a transcriptome and long-term self-renewal capacity similar to those of adult haematopoietic stem cells, and can be used for clonal engraftment and serial primary and secondary multi-lineage reconstitution, including antigen-dependent adaptive immune function. Inhibition of TGFβ and CXCR7 or activation of BMP and CXCR4 signalling enhanced generation of rEC-HSCs. Pluripotency-independent conversion of endothelial cells into autologous authentic engraftable haematopoietic stem cells could aid treatment of haematological disorders.",
author = "Raphael Lis and Karrasch, {Charles C.} and Poulos, {Michael G.} and Balvir Kunar and David Redmond and Duran, {Jose G.Barcia} and Badwe, {Chaitanya R.} and William Schachterle and Michael Ginsberg and Jenny Xiang and Tabrizi, {Arash Rafii} and Koji Shido and Zev Rosenwaks and Olivier Elemento and Speck, {Nancy A.} and Butler, {Jason M.} and Scandura, {Joseph M.} and Shahin Rafii",
year = "2017",
month = "5",
day = "25",
doi = "10.1038/nature22326",
language = "English",
volume = "545",
pages = "439--445",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "7655",

}

TY - JOUR

T1 - Conversion of adult endothelium to immunocompetent haematopoietic stem cells

AU - Lis, Raphael

AU - Karrasch, Charles C.

AU - Poulos, Michael G.

AU - Kunar, Balvir

AU - Redmond, David

AU - Duran, Jose G.Barcia

AU - Badwe, Chaitanya R.

AU - Schachterle, William

AU - Ginsberg, Michael

AU - Xiang, Jenny

AU - Tabrizi, Arash Rafii

AU - Shido, Koji

AU - Rosenwaks, Zev

AU - Elemento, Olivier

AU - Speck, Nancy A.

AU - Butler, Jason M.

AU - Scandura, Joseph M.

AU - Rafii, Shahin

PY - 2017/5/25

Y1 - 2017/5/25

N2 - Developmental pathways that orchestrate the fleeting transition of endothelial cells into haematopoietic stem cells remain undefined. Here we demonstrate a tractable approach for fully reprogramming adult mouse endothelial cells to haematopoietic stem cells (rEC-HSCs) through transient expression of the transcription-factor-encoding genes Fosb, Gfi1, Runx1, and Spi1 (collectively denoted hereafter as FGRS) and vascular-niche-derived angiocrine factors. The induction phase (days 0-8) of conversion is initiated by expression of FGRS in mature endothelial cells, which results in endogenous Runx1 expression. During the specification phase (days 8-20), RUNX1 + FGRS-transduced endothelial cells commit to a haematopoietic fate, yielding rEC-HSCs that no longer require FGRS expression. The vascular niche drives a robust self-renewal and expansion phase of rEC-HSCs (days 20-28). rEC-HSCs have a transcriptome and long-term self-renewal capacity similar to those of adult haematopoietic stem cells, and can be used for clonal engraftment and serial primary and secondary multi-lineage reconstitution, including antigen-dependent adaptive immune function. Inhibition of TGFβ and CXCR7 or activation of BMP and CXCR4 signalling enhanced generation of rEC-HSCs. Pluripotency-independent conversion of endothelial cells into autologous authentic engraftable haematopoietic stem cells could aid treatment of haematological disorders.

AB - Developmental pathways that orchestrate the fleeting transition of endothelial cells into haematopoietic stem cells remain undefined. Here we demonstrate a tractable approach for fully reprogramming adult mouse endothelial cells to haematopoietic stem cells (rEC-HSCs) through transient expression of the transcription-factor-encoding genes Fosb, Gfi1, Runx1, and Spi1 (collectively denoted hereafter as FGRS) and vascular-niche-derived angiocrine factors. The induction phase (days 0-8) of conversion is initiated by expression of FGRS in mature endothelial cells, which results in endogenous Runx1 expression. During the specification phase (days 8-20), RUNX1 + FGRS-transduced endothelial cells commit to a haematopoietic fate, yielding rEC-HSCs that no longer require FGRS expression. The vascular niche drives a robust self-renewal and expansion phase of rEC-HSCs (days 20-28). rEC-HSCs have a transcriptome and long-term self-renewal capacity similar to those of adult haematopoietic stem cells, and can be used for clonal engraftment and serial primary and secondary multi-lineage reconstitution, including antigen-dependent adaptive immune function. Inhibition of TGFβ and CXCR7 or activation of BMP and CXCR4 signalling enhanced generation of rEC-HSCs. Pluripotency-independent conversion of endothelial cells into autologous authentic engraftable haematopoietic stem cells could aid treatment of haematological disorders.

UR - http://www.scopus.com/inward/record.url?scp=85019691791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019691791&partnerID=8YFLogxK

U2 - 10.1038/nature22326

DO - 10.1038/nature22326

M3 - Article

VL - 545

SP - 439

EP - 445

JO - Nature

JF - Nature

SN - 0028-0836

IS - 7655

ER -